619: N-[(E)-3-[(2R,3S,4R,5R)-5-(6-ethylaminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]prop-2-enyl]-5-(4-fluorophenyl)-2,3-dihydroxy-benzamide
619 is a Ligand Of Interest in 5LQA designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 5LQA_619_A_302 | 100% | 37% | 0.048 | 0.99 | 1.36 | 1.13 | 4 | 3 | 0 | 0 | 100% | 1 |
| 3HVI_619_A_267 | 99% | 36% | 0.055 | 0.987 | 1.01 | 1.5 | 2 | 6 | 0 | 0 | 100% | 1 |
| 5LQU_619_B_301 | 96% | 31% | 0.067 | 0.976 | 1.11 | 1.64 | 3 | 5 | 2 | 0 | 100% | 1 |
